For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Cytovia, Inc.

USPTO Granted Patents = 47

% Expired Patents = 68.1

CIPO Patents = 1

EPO Patents = 1

Forward Citations = 614

Loading Chart...

Loading Chart...

44 inventors (with patents filed for the assignee):

Sui Xiong Cai (45 out of 87 patents)

John A Drewe (30 out of 30 patents)

Han-Zhong Zhang (21 out of 21 patents)

4. Shailaja Kasibhatla (13 out of 23 patents)

5. Eckard Weber (10 out of 70 patents)

6. Yan Wang (8 out of 40 patents)

7. Hong Zhang (7 out of 30 patents)

8. Songchun Jiang (7 out of 16 patents)

9. John F W Keana (7 out of 28 patents)

10. Jared Kuemmerle (6 out of 6 patents)

11. P Sanjeeva Reddy (6 out of 6 patents)

12. William E Kemnitzer (6 out of 6 patents)

13. Nilantha Sudath Sirisoma (5 out of 7 patents)

14. Ben Y Tseng (5 out of 5 patents)

15. Douglas R Green (5 out of 9 patents)

Core Competencies:

Caspases

Apoptosis

Gambogic Acid

Fluorescent Reporters

Protease Inhibitors

Oxadiazoles

Chalcones

Coumarins

Quinolines

Dipeptides

Screening Assays

Nicotinamides

47 patents: Sort by Forward Citations

1. 7968595 - Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof (2011-06-28),

2. 7732468 - [object Object] (2010-06-08),

3. 7622497 - Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis (2009-11-24),

4. 7618975 - 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof (2009-11-17),

5. 7592143 - Methods of treating diseases responsive to induction of apoptosis and screening assays (2009-09-22),

6. 7528164 - Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof (2009-05-05),

7. 7507762 - [object Object] (2009-03-24),

8. 7504382 - Protease inhibitors for coronaviruses and SARS-CoV and the use thereof (2009-03-17),

9. 7476741 - Substituted 4H-chromens, 2H-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof (2009-01-13),

10. 7435750 - Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof (2008-10-14),

11. 7317029 - 3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof (2008-01-08),

12. 7270801 - Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof (2007-09-18),

13. 7256219 - Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof (2007-08-14),

14. 7235674 - Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof (2007-06-26),

15. 7226927 - Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof (2007-06-05),

Cytovia, Inc. is a biotechnology company based in San Diego, California, specializing in the development of innovative therapeutics that target apoptosis pathways. The company focuses on a range of technologies, including caspase activators and inhibitors, apoptosis inducers, and protease inhibitors, to advance cancer treatment and other diseases. Cytovia's research also encompasses fluorescent reporter molecules and unique chemical compounds, such as gambogic acid derivatives and oxadiazole compounds, aimed at enhancing drug discovery and therapeutic efficacy.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

47 Patents

#129 in San Diego, CA

#1,752 in California

#7,425 in US

#14,796 in the World

San Diego, CA, United States of America

Cytovia, Inc.

Forward Citations = 614

44 inventors:

Sui Xiong Cai (45 out of 87 patents)

John A Drewe (30 out of 30 patents)

Han-Zhong Zhang (21 out of 21 patents)

4. Shailaja Kasibhatla (13 out of 23 patents)

5. Eckard Weber (10 out of 70 patents)

Please report any incorrect information to [email protected]

Loading…